Oncology

Article	Citations
The utility of the new category by number of stations for lymph nodal involvement in non-small cell lung cancer	97
Atezolizumaba plus bevacizumab is Associated with Favorable Overall Survival Over Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma	28
Front & Back Matter	21
Skin Cancer Detection in Diverse Skin Tones by Machine Learning Combining Audio and Visual Convolutional Neural Networks	19
Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors	17
Retacrit®, Biosimilar of Epoetin Alfa, in Chemotherapy-Induced Anemia in Routine Practice: Impact of Iron Supplementation	16
Polymorphism in Thymidylate Synthase Gene Predicts Survival and Toxicity in North Indian Lung Cancer Patients Undergoing Platinum-Based Doublet Chemotherapy	15
Alpha-2-Macroglobulin Is a Novel Anticancer Agent	14
Front & Back Matter	13
Exploration of Extracellular Vesicle Long Non-Coding RNAs in Serum of Patients with Cervical Cancer	11
Cancer-Predisposition Genetic Analysis in Children with Brain Tumors Treated at a Single Institution in Japan	11
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab	10
Combined Interaction of Cellular and Extracellular Components Causes Genetic Cascade Activation in Breast Cancer Metastasis	10
Lenvatinib Might Induce Activation of Host Immunity in Patients with Hepatocellular Carcinoma	10
An Analysis of 20 Cases of Radiation-Associated Sarcoma, Including 4 Cases Treated by Carbon Ion Radiotherapy	10
Predictive Ability of Rule of 3 in Parathyroid Cancer: Outcomes from a South Asian Cohort	10
Effects of Exercise during Chemo- or Radiotherapy on Immune Markers: A Systematic Review	9
Survival Outcome in Early-Onset Metastatic Colorectal Cancer: A Multicenter-Matched Pair Analysis	9
Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer	9
Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin Plus Etoposide Therapy	9
Predictive Value of Preoperative Peak Oxygen Uptake for Postoperative Pulmonary Complications in Lung Cancer Patients with Chronic Obstructive Pulmonary Disease: A Single-center Retrospective Cohort S	9
Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Advanced Pancreatic Cancer: A Real-World Study	9
Front & Back Matter	9
Determining the cut-off value of the MASCC Score to predict mortality in hospitalized febrile neutropenic patients: A decade-long single-center retrospective cohort study	9
Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study	8

The Potential of ESCO2 as a Prognostic and Immunotherapeutic Marker of Pan-Cancer and Its Role in Anti-PD-1 Treatment of Bladder Cancer	8
Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study)	8
Clinical Significance of the Post/Preoperative Anti-p53 Antibody Ratio in Predicting the Prognosis of Patients with Colorectal Cancer after Curative Surgery and Its Usefulness in Combination with Carc	7
High Expression of Cancer-Derived Sialylated Immunoglobulin G: A Novel Biomarker for Poor Prognosis in Laryngeal Squamous Cell Carcinoma	7
The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung Cancer	7
Evaluation of Cardiac Adverse Events with Ponatinib Using a Spontaneous Reporting Database	7
Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular Carcinoma	7
The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis	7
A real-world pharmacovigilance analysis for Demethylation drug: findings from the FDA adverse event reporting database	7
Factors Affecting Recurrence and Survival in Stage IIA Colon Cancer Patients	7
Characteristics and Risk Factors of Immune Checkpoint Inhibitor-related Pneumonitis in Non-small Cell Lung Cancer: A Retrospective Study	7
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology	7
Suppression of Local Tumor Progression in Perivascular Hepatocellular Carcinoma by Combination Therapy with Radiofrequency Ablation and Percutaneous Ethanol Injection: A Propensity Score Matching Anal	6
Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint Inhibitors	6
Impact of Relative Dose Intensity of Docetaxel, Cisplatin, and 5-Fluorouracil Neoadjuvant Chemotherapy on Survival of Esophageal Squamous Cell Cancer Patients	6
Modified albumin-bilirubin grade and alpha-fetoprotein score for predicting prognosis of hepatocellular carcinoma patients undergoing conventional transarterial chemoembolization	6
Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin versus Those with Extremities/Trunk Origin	6
Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance Database	6
Absolute Lymphocyte Count as an Independent Prognostic Factor in Metastatic Breast Cancer: A Retrospective Study	6
Evaluating the Response of Palbociclib on Progression-Free Survival in Hormone Receptor-Positive Metastatic Breast Cancer	5
Chronic Myeloid Leukemia in Adolescents and Young Adults: Clinicopathological Variables and Outcomes	5
Retrospective Analysis: S100 as Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome	5
Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma	5
Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study	5
Serotonin Receptors and Acetylcholinesterase Gene Expression Alternations: The Potential Value on Tumor Microenvironment of Gastric Cancer	5
SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma	5
Front & Back Matter	5
Concomitant Use of Proton Pump Inhibitors and CDK4/6 inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real World Cohort Study	5
Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy	5
Body Mass Index, Sarcopenia, and Their Variations in Predicting Outcomes for Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma	5
Is Total Neoadjuvant Treatment Beneficial for Locally Advanced Rectal Cancer? A Meta-Analysis of Randomized Controlled Trials	5
Contents Vol. 100, 2022	5
Utilization of 18F-FDG Standardized Uptake Value and Metabolic Tumor Volume to Predict Local Failure in Nasopharyngeal Carcinoma	5
Diagnostic Value of OPNI in Hepatocellular Carcinoma	5
Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience	5
Beyond Front-Line Therapy for Unresectable Gastroesophageal Adenocarcinoma: Are There Differences in Subsequent Therapy Sequencing?	5
The Clinical Relevance of the Expression of SGLT2 in Lung Adenocarcinoma	5
Predicting Trifluridine/Tipiracil Treatment Outcomes in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis	4
Targeted Therapies and Utility of the Lung-molGPA in Non-Small-Cell Lung Cancer Patients with Brain Metastases	4
Decision-Making at Swissmedic, the Swiss Regulatory Agency, with a Focus on (Neo)adjuvant Cancer Treatments	4
Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer	4
The association between body mass index and mortality in breast cancer patients receiving pembrolizumab	4
Relative Efficacies of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Treatment of Recurrent Non-Small Cell Lung Cancer after Surgery	4
Efficacy and Safety of Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma and Child-Pugh Class B: A Retrospective Cohort Study	4
Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies	4
Clinical Impact of Skeletal Muscle Mass and Nutritional Status in Patients with Recurrent or Advanced Gastric Cancer Treated with Nivolumab	4
Development and Validation of a Model Predicting Malignant Potential of Adnexal Masses in Areas with Scarcity of Ultrasound Resources	4
Efficacy and Safety of Autologous Stem Cell Transplantation in First-Line Treatment and at Relapse in Elderly Patients with Multiple Myeloma	4
Expression of Human Endogenous Retrovirus env-gene product is a hallmark of sidedness in operable colorectal cancer	4
Eribulin in Patients with Liposarcoma and Leiomyosarcoma: A Retrospective Single-Center Experience	4

Analysis of immune related adverse events of pembrolizumab using FAERS database	4
Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer	4
Immunotherapy plus Chemotherapy for Patients with EGFR-Mutated Non-Squamous Cell Lung Cancer for Disease Progression after EGFR Tyrosine-Kinase Inhibitor: A Meta-Analysis of Randomized Controlled Tria	4
Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck	4
Clinical Significance of Biliary Invasion at Diagnosis in Barcelona Clinic Liver Cancer Stage B–C Hepatocellular Carcinoma: A Nationwide Cohort Analysis in South Korea	4
Significance of Gene Polymorphism and Gene Expression of BACE2 in Swedish Patients with Colorectal Cancer	4
Clinical T2N0 Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy plus Local Excision	4
The Know-how Post-transplant Skin cancer for Immunotherapy and target therapies	3
Health-Related Quality of Life in a Real-World Cohort of Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors	3
A Retrospective Analysis of the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors at The Ottawa Hospital Cancer Center over the Last Decade Including COVID-19 Pandemic Period	3
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma	3
Prognostic significance of modified Glasgow Prognostic Score in patients undergoing FOLFOXIRI plus bevacizumab therapy for advanced or metastatic colorectal cancer	3
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study	3
Circulating Tumor Cells as Diagnostic Markers of Early Gastric Cancer and Gastric Precancerous Lesions	3
A Comparative Study On The Progression Of Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms	3
Germline Mutations in 32 Cancer Susceptibility Genes by Next-Generation Sequencing among Breast Cancer Patients	3
The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth	3
The Rate of Clinically Significant Prostate Cancer on Repeat Biopsy after a Diagnosis of Atypical Small Acinar Proliferation: A Systematic Review and Meta-Analysis	3
Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced Gastric Cancer	3
Malignant Primary and Metastatic Cardiac Tumors: A Single-Center 27-Year Case Review	3
Pattern of Expression of MicroRNA in Patients with Radiation-Induced Bladder Injury	3
Lobectomy with Lymph Node Dissection Benefits N3 Stage Non-Small Cell Lung Cancer Patients: A Population-Based Study	3
Dose Modification of Etoposide plus Platinum in Elderly Patients with Extensive-Disease Small-Cell Lung Cancer	3
Association of Insulin Receptor Substrate 1 Expression in the Prognosis of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis	3
Clinical Significance of the Preoperative Inflammatory Burden Index in Esophageal Cancer	3
Effects of chemotherapy( Anthracyclin, Cyclophosphamide following docetaxel regimen) on sleep, anxiety, depression and quality of life in patients with breast cancer	3
Prognostic and Immunotherapeutic Role of TACC3 in Pancancer and Its Impact on Proliferation and Docetaxel Resistance in Lung Adenocarcinoma	3
Comparing the efficacy of a triplet antiemetic regimen in patients with esophageal cancer patients and diabetes mellitus treated with cisplatin-based chemotherapy: A retrospective study	3
Prognostic Value of a Novel Index Combining the Prognostic Nutritional Index and D-Dimer Levels for Gastric Cancer after Gastrectomy	3
GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma	3
Co-Culture Device for in vitro High Throughput Analysis of Cancer-Associated Fibroblast and Cancer Cell Interactions	3
Response to – Clinico-Radio-Histo-Molecular and Neurocognitive Characteristics of Diffuse Gliomas in Adolescent and Young Adults: A Comprehensive Review	3
Trends in Gastric Cancer Mortality in Montenegro, 1990–2018: Joinpoint Regression	3
PREVES: A Population-Based Survey Focused on Cancer and Nutrition	3
Correlation of Baseline Tumor Burden with Clinical Outcome in Melanoma Patients Treated with Ipilimumab	3
Investigating the Correlation between the Cytological Grading System and CT Features in Early-Stage Lung Adenocarcinoma	3
Investigating the Mechanism of Hedysarum Multijugum Maxim in the Treatment of Liver Cancer through Network Pharmacology and Molecular Docking Validation	3
Effects of Laughter Therapy on Improving Negative Emotions Associated with Cancer: A Systematic Review and Meta-Analysis	3
High-Mobility Group Box 1 Overexpression Predicts a Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Gastric Cancer by Activating TLR4/NF-κB Signaling	3
Hidden Resources for Cancer Patients – Interactions between spirituality, religiosity and selected factors influencing patient’s self-care	3
Comparison of the efficacy of nal-IRI+5FU/LV and S-1 in patients with advanced pancreatic cancer refractory to gemcitabine and nab-paclitaxel	3
Gender, Racial, and Geographical Disparities in Malignant Brain Tumor Mortality in the USA	3
Increased Spleen Volume in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab in Comparison to Lenvatinib: A Retrospective Analysis	3
Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma	3
Anti-Histamines Improve the Survival of Lung Cancer: a 10-year Cohort Study of Tertiary Hospital in Taiwan	3
Total Neoadjuvant Therapy Approach for the Treatment of Locally Advanced Rectal Cancer: Where Do We Stand?	3
Formin-Like 2 Is a Potential Biomarker of Poor Prognosis in Nasopharyngeal Carcinoma	2
Genome-Wide Analysis of DNA Methylation in Pseudomyxoma Peritonei Originated from Appendiceal Neoplasms	2
Pan-Cancer Analysis of the Prognostic and Immunological Role of <i>SMG5</i>: A Biomarker for Cancers	2
Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study	2
Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer	2
Erratum	2
Favorable Impact of Serum TERT C228T for Prognosis after Surgical Resection for Liver Cancer	2
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy	2
Contents Vol. 101, 2023	2
Localized Gastroesophageal Adenocarcinoma in the Elderly: Is Age a Factor Associated with Suboptimal Treatment?	2
Lower Body Mass Index and Prognostic Nutritional Index Are Associated with Poor Posttransplant Outcomes in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation	2
Trophoblast Cell Surface Antigen 2 (Trop2) in Chromophobe Renal Cell Carcinoma	2
Clinico-Radio-Histo-Molecular and Neurocognitive Characteristics of Diffuse Gliomas in Adolescent and Young Adults: A Comprehensive Review	2
Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients	2
Patient-reported outcome-based symptom management improves QoL in postoperative gastroesophageal cancer patients: A Randomized Controlled Trial	2
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study	2
Epidemiologic and Clinical Patterns of Malignant Lymphoma in Qatar 2013–2017: A Population-Based Cohort Study	2
Front & Back Matter	2
Prognostic impact of recurrence pattern for surgically resected non-small cell lung cancer	2
Development of an Artificial Intelligence System for Distinguishing Malignant from Benign Soft-Tissue Tumors Using Contrast-Enhanced MR Images	2
Non-small cell lung cancer treated with epidermal growth factor receptor inhibitors: the effect of concurrent medications on patient outcomes	2
Evaluation of Time to Onset and Outcome of Cardiac Adverse Events Associated with Nilotinib using Post-Marketing Surveillance	2
Comprehensive Analysis of Bortezomib-Induced Adverse Events Using the Japanese Real-World Database	2
The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer	2
Stage I Non-Seminomatous Testicular Cancer. Long-term follow-up with surveillance approach post-orchiectomy.	2
The Glasgow Prognostic Score as a Predictor of Survival after Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer	2
Hypo-fractionated versus standard fractionation radiotherapy in frail and elderly patients with central nervous system solitary fibrous tumors.	2
Racial and Geographic Differences in Endometrial Cancer Death	2
Prognostic Impact of Reactive Oxygen Species Modulator 1 in Surgically Resected Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas	2
ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis	2
Biological Difference between L858R and Exon 19 Deletion Contributes to Recurrence-Free Survival of Resected Non-Small Cell Lung Cancer	2
Long-Term Survival Outcomes in Locally Advanced Breast Cancer after Mastectomy with or without Breast Reconstruction	2
Risk for Second Primary Ovarian Cancer: A Large Population Based on Surveillance, Epidemiology, and End Results Database	2
Decision-Making among Experts in Advanced Hodgkin Lymphoma	2

Glucose Conferred Irinotecan Chemoresistance through Divergent Actions of Pyruvate and ATP in Cell Death and Proliferation of Colorectal Cancer	2
Evaluation of Clinical Significance of Lymphovascular Space Invasion in Stage IA Endometrial Cancer	2
Kinesin Family Member B18 Is Related to Gastric Mucin Phenotype and Contributes to Gastric Cancer Progression by Regulating Epithelial-Mesenchymal Transition	2
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging-Defined Extramural Venous Invasion Predicts Distant Metastasis and Reflects Strong Tumor Invasiveness in Rectal Cancer	2
Clinical Impact of Early Tumour Shrinkage in Metastatic or Unresectable Oesophageal Cancer Treated with Pembrolizumab plus Chemotherapy	1
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer	1
Erratum	1
Regorafenib Combination Therapy in Advanced Hepatocellular Carcinoma: With or Without Transarterial Chemoembolization	1
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian Cancer	1
Endogenous and extracellular roles of a tumor suppressor miR-379-5p in gastric cancer	1
Genetic Variants in Histone Modification Regions Predict Clinical Outcomes of Pemetrexed Chemotherapy in Lung Adenocarcinoma	1
Development of a Diagnostic Model for Pancreatic Ductal Adenocarcinoma Using Machine Learning and Blood-Based miRNAs	1
Oral Abundance of <b><i>Actinomyces</i></b> spp. in Breast Cancer Patients	1
The Complex Management of the Breast Angiosarcoma: A Retrospective Study	1
Front & Back Matter	1
Significance of TYMS Polymorphism rs3819102 as a Prognostic Marker for Nonsmoking Lung Cancer Patients of the Han Ethnicity in China	1
The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer	1
Long-term survival of node-positive breast cancer with complete nodal response to neoadjuvant chemotherapy treated with sentinel lymph node biopsy alone: A meta-analysis	1
Radiomics Correlation to CD68+ Tumor-Associated Macrophages in Clear Cell Renal Cell Carcinoma	1
Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia	1
MUC17 is a potential new prognostic biomarker and promotes pancreatic cancer progression in obstructive jaundice	1
Disproportionality Analysis of Stomatitis Associated with Anticancer Drugs Using the Japanese Adverse Drug Event Report Database	1
Front & Back Matter	1
Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study	1
Efficacy of Fusion Imaging and Cone-Beam Computed Tomography Guided Radiofrequency Ablation for Hepatocellular Carcinoma Poorly Visualized on Ultrasonography	1
Erratum	1
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade	1
Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors	1
Eribulin Treatment for Patients with Metastatic Breast Cancer: The UK Experience – A Multicenter Retrospective Study	1
Prognostic Impact of Hepatic Steatosis Evaluated by CT on Immunotherapy for Gastric Cancer: Associations with Sarcopenia, Systemic Inflammation, and Hormones	1
Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process	1
CA19-9 in Combination with Methylated <b><i>HOXA1</i></b> and <b><i>SST</i></b> Is Useful to Diagnose Stage I Pancreatic Cancer	1
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma	1
RNA Expression-Based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab	1
Circulating Cell-Free DNA as a Biomarker for Prognosis and Response to Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma	1
Clinical Effects and Safety of Intra-Arterial Infusion Chemotherapy with Lipiodol versus Intra-Arterial Infusion Chemotherapy Alone for Treatment of Advanced Hepatocellular Carcinoma	1
Prognostic Value of the Geriatric Nutritional Risk Index in Previously Untreated Patients with Advanced Non-Small Cell Lung Cancer Treated with a Combination Therapy of Anti-PD-1/-PD-L1 Antibodies and	1
Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with Mechanistic Target of Rapamycin Signaling	1
Exosome-derived miR-148a-3p protect against tumor proliferation and metastasis of esophageal squamous carcinoma	1
Evaluation of Time to Onset and Outcome of Lung Adverse Events Related to Pembrolizumab Using Marketing Surveillance	1
Transarterial Chemoembolization Combined with Lenvatinib for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	1
Viral Infections and Incidence of Reactivations in Chronic Myeloid Leukemia Patients	1
Risk Factors of Capecitabine-Induced Hand-Foot Syndrome: A Single-Institution, Retrospective Study	1
TATI, TAT-2, and CRP as Prognostic Factors in Colorectal Cancer	1
Variations in Characteristics and Clinical Outcomes of Esophageal Squamous Cell Carcinoma Among Asian American	1
Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver Metastases	1
A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer	1
Comprehensive Study of Chromosomal Copy Number Variations and Genomic Variations Predicting Overall Survival in Myelodysplastic Syndromes	1
Assessment of Cardiovascular Events Caused by New-Generation Androgen Receptor Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in Japan	1
Analysis of Pleiotropic Effects of Nivolumab in Patients with relapsed Pleural Mesothelioma: A Single center retrospective study	1
Comprehensive Analysis of the Relationship between Cuproptosis-Related Gene GCSH and Prognosis, Tumor Microenvironment Infiltration, and Therapy Response in Endometrial Cancer	1
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor	1
Treatment and reasons for choosing treatment in breast cancer patients who underwent next-generation sequencing test	1
Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer	1
Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma	1
Association of Cancer and Its Interaction with Conventional Risk Factors on Cardiovascular Disease Risk	1
Cardiac Adverse Events Associated with Multiple Myeloma Patients Treated with Proteasome Inhibitors	1
Clinical Efficacy and Safety of Ni<underline>v</underline>olumab in Mal<underline>i</underline>gnant N<underline>o</underline>n-Pleural Mesothe<underline>l<	1
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial	1
The Usefulness of Serum Interleukin-6 as a Predictor of Response to Atezolizumab plus Bevacizumab Combination Treatment in Hepatocellular Carcinoma	1
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma	1
Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy	1
Mechanism research and application prospect of non-coding RNA regulating tumor cell pyroptosis	1
Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell Carcinoma	1
Factors Affecting Pathologic Complete Remission in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy	1
Pretreatment Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patie	1
Plasma Cytokines Pattern as a Prognostic Marker for Esophageal Squamous Cell Carcinoma via Unsupervised Clustering Analyses	1
Effect of Germline <b><i>MEFV</i></b> Polymorphisms on the Prognosis of Japanese Children with Cancer: A Regional Analysis	1
Impact of Oophorectomy on Survival and Improving Nutritional Status in Ovarian Metastasis from Colorectal Adenocarcinoma	1
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals	1
Acknowledgement to Reviewers	1
Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-Up of Prognostic Study Using Propensity Scor	1
Early versus Late Recurrence of Hepatocellular Carcinoma after Microwave Ablation: Patterns, Treatments, and Post-Recurrence Survival	1
Immunohistochemical Expression of Insulin-Like Growth Factor-1 Receptor and Its Association with Clinicopathological Parameters in Hepatocellular Carcinoma	1
Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study	1
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study	1
Constructing and Validating Models for Predicting Gleason Grade Group Upgrading Following Radical Prostatectomy in Localized Prostate Cancer: A Comparison between Machine Learning Algorithms and Conve	1
Dose-Reduction of Bevacizumab in Atezolizumab plus Bevacizumab Therapy Extends Treatment duration with Disease Control in Patients with Hepatocellular Carcinoma	1
Novel index based on inflammatory markers correlates with treatment efficacy of nivolumab for recurrent/metastatic head and neck cancer	1
Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma	1
Peripheral Blood-Derived CircVPS35L as a Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer	1
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer	1